Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.

ABSTRACT:

SUBMITTER: Hillmen P 

PROVIDER: S-EPMC5927988 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature